Yoshiko Homma

654 citations
15 papers · 453 indexed · h-index 10
Topics
Microbial Natural Products and Biosynthesis (6 papers)Peptidase Inhibition and Analysis (3 papers)Ubiquitin and proteasome pathways (3 papers)
Journals
The Journal of AntibioticsPubMedActinomycetologica
Partner nations
Japan

In The Last Decade

Yoshiko Homma

15 papers receiving 443 citations

Peers

Yoshiko Homma
Comparison fields: 5 of 64
  • Molecular Biology 254
  • Pharmacology 202
  • Organic Chemistry 156
  • Biotechnology 75
  • Oncology 60
Replace Paolo Tavecchia with:
Paolo Tavecchia Italy
Akira Mukai Japan
Chigusa Hayashi Japan
Keiko Furihata Japan
Koichiro Ootsu Japan
AKIO TORIKATA Germany
Kristiina Ylihonko Finland
Chaoxuan Li United States
J Lunel France
Katrin Welzel Germany
Yoshiko Homma relative to Paolo Tavecchia Italy Paolo Tavecchia's profile →
Citations per field
00.5×10×15×22×
Paolo Tavecchia · 1×
Citations per year

Countries citing papers authored by Yoshiko Homma

Since Specialization
Citations

This map shows the geographic impact of Yoshiko Homma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiko Homma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiko Homma more than expected).

Fields of papers citing papers by Yoshiko Homma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiko Homma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiko Homma. The network helps show where Yoshiko Homma may publish in the future.

Co-authorship network of co-authors of Yoshiko Homma

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiko Homma. A scholar is included among the top collaborators of Yoshiko Homma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiko Homma. Yoshiko Homma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 4
2 27
3 35
4 7
5 15
6 43
7 35
8 107
9 34
10 6
11 50
12 7
13 27
14 51
15
Antibacterial activity of dibekacin against gentamicin-resistant organisms.
5

About Yoshiko Homma

Yoshiko Homma is a scholar working on Microbiology, Pharmacology and Toxicology, having authored 15 papers that have together received 453 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Peptidase Inhibition and Analysis (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Microbiology (50 citations), Pharmacology (202 citations) and Biotechnology (75 citations). Yoshiko Homma has collaborated with scholars based in Japan. Frequent co-authors include MASA HAMADA, Naoko Kinoshita, TSUTOMU SAWA, TOMIO TAKEUCHI, Masayuki Igarashi, Yuya Yoshimoto, HIRONOBU IINUMA, Koichi Nakae, Masaya Imoto and Ryûichi Sawa. Their work appears in journals such as The Journal of Antibiotics, PubMed and Actinomycetologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026